The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical activity of pembrolizumab monotherapy in diffuse malignant peritoneal mesothelioma.
 
Xiao Wang
No Relationships to Disclose
 
Michael Offin
Honoraria - OncLive
Consulting or Advisory Role - American Society for Radiation Oncology; Jazz Pharmaceuticals; Novartis; PharmaMar; Targeted Oncology
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Sharp & Dohme
 
Leonid Roshkovan
No Relationships to Disclose
 
John Miura
No Relationships to Disclose
 
Michelle S. Ginsberg
No Relationships to Disclose
 
Christine Agnes Ciunci
Honoraria - Imedex; Imedex; Merck
Research Funding - Bristol Myers Squibb (Inst); Celgene (Inst); MacroGenics (Inst); Merck (Inst)
 
Jacklynn V. Egger
No Relationships to Disclose
 
Suzanne Walker
Stock and Other Ownership Interests - AstraZeneca/Merck; Pfizer
Honoraria - Exelixis; Genentech
 
Andrea Cercek
Consulting or Advisory Role - Bayer; GlaxoSmithKline; Incyte; Janssen; Merck; Seagen
Research Funding - GlaxoSmithKline; Rgenix (Inst); Seagen
 
Leslie Litzky
No Relationships to Disclose
 
Garrett Michael Nash
No Relationships to Disclose
 
Andrew Haas
Consulting or Advisory Role - Novocure; Olympus; Serpex Medical
 
Giorgos Karakousis
No Relationships to Disclose
 
Keith A. Cengel
Stock and Other Ownership Interests - Symphotek; Symphotek
Consulting or Advisory Role - Novocure
Patents, Royalties, Other Intellectual Property - US20190099491A1 Sensitizing Cells to Proton Radiation; US9999779B2 Cell, tissue and organ protection using a magnetic field
Travel, Accommodations, Expenses - Novocure
 
Sharyn I. Katz
Consulting or Advisory Role - Trizell
Research Funding - Novartis
 
Marjorie Glass Zauderer
Honoraria - Medical Learning Institute; OncLive Clinical Congress Consultants; Research to Practice
Consulting or Advisory Role - Aldeyra Therapeutics; GlaxoSmithKline; Novocure; Takeda
Research Funding - Atara Biotherapeutics (Inst); Bristol-Myers Squibb (Inst); Curis (Inst); Epizyme (Inst); GlaxoSmithKline (Inst); Millennium (Inst); Polaris (Inst); Sellas Life Sciences (Inst)
(OPTIONAL) Uncompensated Relationships - Mesothelioma Applied Research Foundation
 
Corey J. Langer
Honoraria - AstraZeneca; Bristol-Myers Squibb; Genentech/Roche; Lilly/ImClone; Merck; Takeda Science Foundation
Consulting or Advisory Role - Abbott Biotherapeutics; ARIAD; AstraZeneca; Bayer/Onyx; Bristol-Myers Squibb; Cancer Support Community; Celgene; Clarient; Clovis Oncology; Genentech/Roche; Gilead Sciences; Lilly/ImClone; Merck; Novocure; Pfizer; Regeneron; Takeda
Research Funding - Advantagene (Inst); Amgen; Ariad (Inst); AstraZeneca; Celgene (Inst); Clovis Oncology (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Inovio Pharmaceuticals (Inst); Johnson & Johnson/Janssen; Lilly; Merck (Inst); Stem CentRx (Inst); Trizell (Inst)
Other Relationship - Amgen; Lilly; OncoCyte; Peregrine Pharmaceuticals; Synta
 
Melina Elpi Marmarelis
Stock and Other Ownership Interests - Bluebird Bio; Gilead Sciences; Johnson & Johnson; Merck; Pfizer; Portola Pharmaceuticals
Honoraria - AstraZeneca; Blueprint Medicines; Blueprint Medicines; Health Advances (I); Janssen Oncology; Novocure; Takeda; Targeted Oncology
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb/Celgene; Ikena Oncology
Research Funding - AstraZeneca (Inst); Lilly (Inst); Trizell (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; Novocure
Other Relationship - Novartis